Revance Therapeutics shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.1M | 7.5M | 0.81 |
| 2023-06-30 | $15M | 14M | 1.06 |
| 2023-03-31 | $6.2M | 5.0M | 1.23 |
| 2022-12-31 | $6.0M | 6.5M | 0.92 |
| 2022-09-30 | $11M | 10M | 1.09 |
| 2022-06-30 | $11M | 14M | 0.81 |
| 2022-03-31 | $15M | 16M | 0.94 |
| 2021-12-31 | $14M | 16M | 0.88 |
| 2021-09-30 | $17M | 15M | 1.15 |
| 2021-06-30 | $15M | 13M | 1.17 |
| 2021-03-31 | $7.9M | 7.0M | 1.13 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors